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Abstract
Background: Hospital readmissions are increasingly used as an indicator of quality 
in health care. One potential risk factor of readmissions is polypharmacy. No studies 
have explored the patients’ perspectives on the medication relatedness and potential 
preventability of their readmissions.
Objective: To compare the patients’ perspectives on the medication relatedness and 
potential preventability of their readmissions with the providers’ perspectives.
Methods: Patients unplanned readmitted within 30 days after discharge at one of the 
participating departments of OLVG Hospital in Amsterdam were interviewed during 
their readmission. Patients’ perspectives regarding medication relatedness of their 
readmissions, the potential preventability, possible preventable interventions, and 
satisfaction with medication information were examined. Health-care providers also 
reviewed files of these readmitted patients. Primary outcome was the percentage of 
medication-related and potentially preventable readmissions according to the patient 
vs the provider. Descriptive data analysis was used.
Results: According to patients, 36 of 172 (21%) readmissions were medication-re-
lated, and of these, 21 (58%) were potentially preventable. According to providers, 
26 (15%) readmissions were medication-related and 6 (23%) of these were potentially 
preventable. Patients and providers agreed on the medication relatedness in 11 of 
the 172 readmissions, and in two of these, agreement on the potential preventability 
existed. According to patients, preventive interventions belonged mostly to the hos-
pital level, followed by the primary care level and patient level.
Conclusion: Patients and providers differ substantially on their perspectives regard-
ing the medication relatedness and preventability of readmissions. Patients were 
more likely to view medication-related readmissions as preventable.
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1  | INTRODUC TION
Unplanned hospital readmissions within 30 days are increasingly 
used as an indicator of quality and safety in health care.1-3 This 
assumed that readmissions are preventable. Measuring the pre-
ventability of readmissions is a challenge, because uniform fac-
tors related to preventable readmissions and a clear definition 
of ‘preventability’ have not been established.4-7 Feigenbaum et 
al8 found that on average, 8.7 factors contributed to each po-
tentially preventable readmission. Those factors frequently oc-
curred during follow-up care and were related to transition care 
planning and care coordination. Medication management was a 
factor in more than a quarter of readmissions, including med-
ication errors during or after index admission and inadequate 
patient and caregiver understanding of medication manage-
ment. The existing literature on medication-related readmissions 
shows that a median of 21% of readmissions are due to med-
ication and 5%-87% (median 69%) of these readmissions were 
deemed preventable.9 The risk for medication-related problems 
increases with polypharmacy. A review indicates that 18%-38% 
of patients report medication-related problems after hospital 
discharge.10
As the patient is the only constant factor in the care continuum, 
information from the patient is needed to get insight into medica-
tion-related problems occurring between discharge from hospital 
and readmission. Kari et al11 show that patient involvement is es-
sential in detecting medication-related problems, because otherwise 
poor therapy control, non-optimal medication use, or intentional or 
unintentional non-adherence might be missed.
However, studies investigating patients’ perspectives on medi-
cation relatedness and preventability of these readmissions are lack-
ing. Consensus between patients and providers with respect to the 
role of medication as a potential cause of readmissions is necessary 
to achieve optimal pharmacotherapy.12 If a readmission is caused by 
medication according to the patient without being aware that his 
provider is not convinced of a causal association, a patient could stop 
independently with the suspicious medication resulting in non-ad-
herence. On the other hand, if a provider believes the readmission 
is caused by medication but the patient is unaware of the provider's 
perspective, medication could still be taken by the patient resulting 
in a repeated readmission.
First, the aim of this study is to describe patients’ perspectives 
on the medication relatedness and potential preventability of their 
readmissions and compare these with providers’ perspectives. 
Secondly, we describe the patients’ perspectives regarding interven-
tions that could have prevented medication-related readmissions 
and the patients’ satisfaction with information about medication 
during the index admission.
2  | METHOD
2.1 | Design and setting
The data for this cross-sectional observational study were collected 
within the context of a larger study on all-cause readmissions. This 
current study however focuses on medication-related readmissions. 
The study was performed at OLVG, a general teaching hospital in 
Amsterdam, the Netherlands, from July 2016 until May 2017. A list 
with readmissions within 30 days of discharge was generated within 
the hospital information system and daily screened by the research 
coordinator for eligibility.
Patients ≥18 years readmitted within 30 days after an index ad-
mission (first admission) to one of the departments of cardiology, 
gastro-enterology, internal medicine, neurology, psychiatry, pul-
monology and surgery were interviewed during their readmission. 
Patients were excluded if they were transferred to another hospital 
or self-discharged, or when it was not the first readmission of the 
patient and if the readmission was due to attempted suicide or when 
the patient did not use any medication at all. Furthermore, a read-
mission was excluded if it was scored by providers (see below) as 
unrelated to the index admission. This was done to exclude 30-day 
readmissions that occurred coincidentally. For example, a patient ad-
mitted with pneumonia discharged in a good clinical condition and 
readmitted within 30 days due to a traffic accident. Finally, providers 
had access to the interviews and registered whether they had used 
the interview in their review to assess the preventability of a read-
mission. If a patient interview was used by providers, this interview 
was excluded as well. The study was approved by the local review 
board of the hospital (ACWO-MEC, registration number: 16-028). 
Patient data were obtained and handled in accordance with privacy 
regulations.
2.2 | Pharmaceutical care during the 
index admission
In the OLVG Hospital, two different processes are carried out to im-
prove continuity of pharmaceutical care.13
• On the departments of cardiology, pulmonology, internal medicine, 
gastroenterology and neurology, our hospital has implemented 
a Transitional Pharmaceutical Care (TPC) programme.14 In short, 
hospital pharmacy teams perform medication reconciliation at 
hospital admission and discharge using the dispensing history of 
the community pharmacy and information from the patient/carer 
himself. Any discrepancies between a patient's actual medication 
use and the medication prescribed in hospital are discussed with 
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the resident. No formal medication review is performed. However, 
obvious errors in the pharmacotherapy are eliminated, for example 
lack of a laxative when an opioid is prescribed or no indication for 
hypnotics at discharge, addressing a stop date for antibiotics or opi-
oids. The reason for medication changes is explained to the patient 
during discharge counselling, and a written medication summary is 
provided. The pharmacy team makes a TPC-medication overview 
that the resident could upload into the discharge letter.
• On the departments of psychiatry and surgery, residents and nurses 
are responsible for assessing a patient's actual medication use by in-
terviewing patients/carers. If regarded necessary, they can request 
the hospital pharmacy to obtain a dispensing history from the com-
munity pharmacy. At hospital discharge, the resident uploads infor-
mation from the hospital's prescribing system or types information 
into the discharge letter to the general practitioner.
2.3 | Patients’ perspectives
Patients were interviewed during their readmission, or three at-
tempts were made by phone in case the patient was already dis-
charged or when a caregiver (family member or partner) needed to 
be approached, or in case of a language barrier or when the patient 
was unable to answer the questions. A structured interview guide 
was developed based on previous studies on readmissions and ex-
pert opinion.15-20 For the purpose of this study, the following main 
topics were included: patients’ perspectives on medication related-
ness, patients’ perspectives on potential preventability and preven-
tive interventions, and patients’ perspectives on medication-related 
information received during index admission (File S1). Additionally, 
the following socio-demographic factors were asked: nationality, liv-
ing situation, educational level and self-experienced health status. 
Format of the questions included multiple-choice, yes/no and free 
text. Interviews were conducted by medical students who received 
the interview guide and were trained for this. Interviews lasted ap-
proximately 30 minutes. During the entire interview period, stu-
dents were supervised by the coordinating physician-researcher. 
Interviewers manually recorded responses on data extraction sheets 
in Access 2010 (Microsoft).
2.4 | Providers’ perspectives
Health-care providers who reviewed the readmissions were resi-
dents of the participating departments and a pharmacist. First, 
providers reviewed complete medical records of the readmitted 
patients to assess whether the readmissions were clinically related 
to the index admissions. If it was clinically related, the medica-
tion relatedness, using the algorithm of Kramer et al,21 and the 
preventability, using a modified algorithm of Schumock et al, were 
assessed.22 Readmissions that were assessed as potentially pre-
ventable by the providers or raised questions after the research 
coordinator's check were included to be discussed once a month, 
during a multidisciplinary meeting with the research coordinator, 
residents and a pharmacist. All readmissions assessed as medica-
tion-related by the residents and pharmacist have been reassessed 
by a senior physician (CS) and a clinical pharmacologist (MJ) to vali-
date the findings.
2.5 | Outcomes
Primary outcome was the percentage of medication-related and po-
tentially preventable readmissions according to the patient vs the 
provider. Secondary outcomes were patients’ perspectives regard-
ing interventions that could have potentially prevented the readmis-
sion and percentage of patients who were satisfied with information 
about medication during their index admission.
2.6 | Data analysis
Quantitative analysis was performed in SPSS version 21.0 (IBM SPSS). 
Data from interviews were analysed in MS Excel 2010 (Microsoft). For 
each question, frequency tables were made. The content of the open 
questions was qualitatively (inductively) independently coded by EU 
and AL. The codes were compared and discussed until consensus was 
reached. Hereafter, both researchers placed the codes into categories, 
which were also discussed until consensus was reached. Each answer 
was classified in one of these categories and presented in frequency 
tables in MS Excel. Patients’ and providers’ perspectives on medication 
relatedness and potential preventability were compared descriptively.
3  | RESULTS
Of 646 readmissions that were screened, 427 (66%) readmissions 
met the inclusion criteria, and 227 interviews were conducted, of 
which 172 (76%) were included in the final data analysis (Figure 1). 
Main reasons that the interview was not conducted were as follows: 
failed attempts to get into contact (n = 50), unwillingness to partici-
pate (n = 39) and cognitive/physical problems (n = 34). One hundred 
fifty interviews (87%) were conducted with patients, 4 (2%) with pa-
tients and caregivers and 18 (10%) with caregivers. The mean age of 
the included patients was 62 years (SD 18), 47% were male, and the 
mean number of the medications at discharge of index admission 
was 9.2 (SD 5.9) (Table 1).
3.1 | Patients’ and providers’ perspectives on 
medication relatedness and potential preventability
Table 2 shows patients’ and providers’ perspectives on medication re-
latedness and potential preventability in 172 readmissions. According 
to patients’ perspectives, 36 (21%) readmissions were medication-
related, of which 21 (58%) were potentially preventable (File S2). The 
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causes (n = 23) of the potentially preventable readmissions according 
to patients were as follows: issues with dosage (n = 8, 35%), for exam-
ple antibiotic discontinued too soon or too high dosage prescribed; 
change in medication (n = 6, 26%), for example medication changes 
that were unclear to the patient; a medication interaction (n = 1, 4%); 
costs (n = 1, 4%); or adherence (n = 1, 4%). In six readmissions (26%), 
the patient described an adverse drug reaction as a cause, but in most 
of those cases, the patient could not pinpoint which medication ex-
actly was responsible for the side-effects. According to providers’ per-
spectives, 26 (15%) readmissions were medication-related, of which 6 
(23%) were potentially preventable. In 11 of the 172 readmissions, pa-
tients and providers agreed on the medication relatedness, and in two 
of these, agreement on the potential preventability existed (File S2).
3.2 | Patients’ perspectives on preventive 
interventions
Of the readmissions that were medication-related and potentially 
preventable according to the patient (n = 21), patients reported 23 
preventative interventions. Hospital-based interventions were 18 
times reported, including performing more diagnostics (33%), im-
proving medication-related information (17%), providing a longer 
hospital stay (17%), treating symptoms/complaints (17%), provid-
ing better aftercare (11%) or reacting faster (6%) (Table 3). In two 
cases, patients reported that general practitioner–based interven-
tions could have prevented the readmission, by reacting faster. Two 
patients reported that he or she could have prevented the readmis-
sion by being adherent to therapy.
3.3 | Patients’ satisfaction on medication-related 
information
Table 4 shows patients’ satisfaction on medication-related informa-
tion. In readmissions that were medication-related but not prevent-
able according to patients’ perspectives (n = 15), patients reported 
in 93% (n = 14) that they had received as much information as they 
needed about medicines compared with 67% (n = 14) in readmis-
sions deemed potentially preventable (n = 21). Also, information 
about side-effects of medicines was more often scored as ‘as much 
information as I needed’ in readmissions not preventable according 
to patients’ perspectives compared with potentially preventable re-
admissions, 87% (n = 13) vs 43% (n = 9), respectively. In 73% (n = 11) 
of the readmissions scored as not preventable, patients received 
written instructions, compared with 57% (n = 12) in readmissions 
scored as potentially preventable.
4  | DISCUSSION
This study shows that according to patients, readmissions are more 
often medication-related (21% of readmissions in patients vs 15% in 
F I G U R E  1   Flow of patients646 readmissions 
screened
427 readmitted 
patients included
227 patients 
interviewed 
Exclusion (n = 219)
- Multiple readmissions n = 122
- Unrelated readmission n = 94 
- Attempted suicide n = 3
Interview was not conducted (n = 200), due to:
- Failed attempts to get into contact n = 50
- Unwillingness to participate = 39
- Cognitive/physical problems n = 34
- Language barrier n = 29
- Severe illness n = 23
- Death n = 13
- Other = 12
172 patients included
Exclusion (n = 55)
- No medication use (n = 3)
- Medication-related questions not answered 
(n = 2)
- Interview was used in providers’ review 
(n = 50)
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providers) and are more often potentially preventable (patients 58% 
vs providers 23%) compared to providers. Patients and providers 
agreed on the medication relatedness in 11 of the 172 readmissions, 
and in two of these, agreement on the potential preventability ex-
isted. Patients reported most often that actions in the hospital were 
needed to potentially prevent readmissions. Patients who stated 
that their readmission was preventable more often reported that 
they lacked information regarding medicines and about side-effects 
and written instructions.
To our knowledge, this is the first study showing the perspec-
tives of patients and providers on the role of medication in re-
admissions. Previous studies have described the perspectives of 
patients and providers on the preventability of all-cause readmis-
sions.8,23-28 A recent European study investigated the opinions of 
all-cause readmitted patients, their carers, nurses and physicians 
on predictability and preventability.27 They found that consensus 
on predictability and preventability of all-cause readmissions was 
poor, especially between patients and professionals (kappa val-
ues ranged from 0.105 to 0.173). This is in line with our study, 
where patients reported more often that the readmissions were 
preventable compared to providers. Also, Smeraglio et al24 found 
that patients often felt more could have been done at discharge to 
prevent readmissions compared to providers. Interestingly, they 
found that nurse case managers more often agreed with the pa-
tients’ perspectives compared to physicians. They hypothesized 
that fundamentally, physicians place more onus on patients to 
self-advocate for care, while nurse case managers emphasize the 
system providing support. This suggests that including the per-
spectives of the nurse case managers could be useful to assess the 
preventability from a broader perspective, including the help that 
the care system could have offered.
Several explanations can be given for the disparities in per-
spectives of patients and providers. First, this can be related to the 
differences in pharmacological knowledge between patients and pro-
viders. When providers review the readmission, they may recognize 
a complication or contraindication from a medication responsible for 
the readmission which the majority of patients would be unaware of. 
For example, if a patient is readmitted because of symptoms of a di-
goxin intoxication, a patient could think this is because of worsening 
of the underlying disease, where a provider will relate this to digoxin. 
Secondly, providers used the information available in the hospital 
to review readmissions and lack information about what happened 
TA B L E  1   Patient and admission characteristics
Patient characteristics n = 172
Interviewee
Patient, n (%) 150 (87)
Patient and caregiver, n (%) 4 (2)
Caregiver, n (%) 18 (10)
Age, mean years (SD) 62 (18)
Male, n (%) 81 (47)
Native Dutch, n (%) 110 (64)
Living situation alone, n (%) 77 (45)
Help with medication use, yes (%) 64 (37)
Education level
Primary (0-8 y of education), n (%) 33 (19)
Secondary (9-12 y of education), n (%) 88 (51)
Higher (>12 y of education), n (%) 49 (28)
Unknown, n (%) 2 (1)
Experienced health status
Moderate/bad, n (%) 63 (37)
Good, n (%) 106 (62)
Missing, n (%) 3 (2)
Number of medicine at discharge (index admission), 
mean (SD)
9 (6)
Admission characteristics
Length of stay, days, mean (SD) 6 (7)
Time between discharge and readmission, mean (SD) 12 (8)
Unplanned index admission, n (%) 139 (80)
Discharge department, n (%)
Surgery 42 (24)
Pulmonology 36 (21)
Internal medicine 32 (19)
Cardiology 30 (17)
Gastroenterology 17 (10)
Neurology 15 (9)
Psychiatry 0 (0)
TA B L E  2   Patients’ and providers’ perspectives on medication relatedness and potential preventability
 Patients’ perspectives
Providers’ perspectives Total readmissions (n = 172) Not medication-
related (n = 136)
Medication-related (n = 36)
Not preventable 
(n = 15)
Potentially preventable 
(n = 21)
Not medication-related (n = 146) 121 9 16
Medication-
related (n = 26)
Not preventable (n = 20) 12 5 3
Potentially preventable 
(n = 6)
3 1 2
Bold values show the number of readmissions with agreement on the medication relatedness. Italic values show the number readmissions with 
agreement on the medication relatedness and preventability between patients and providers.
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after discharge. Therefore, medication-related problems and compli-
ance issues after discharge could be missed. Consequently, providers 
could relate the readmission to worsening of the underlying disease 
and patients could indicate that this is caused by medication-related 
problems. Lastly, patients and providers differed in the perspective 
of the care that was needed. Some patients were dissatisfied at dis-
charge because of different expectations of their admission and the 
continuation of care after discharge, while according to the provid-
ers, adequate standard of care has been provided. All in all, more 
studies are needed to identify the exact reasons for the gap between 
patients’ and providers’ perspectives.
Given the preventive interventions cited by the patients in this 
study: diagnostics, longer hospital stay, treating symptoms and improv-
ing medication-related information, the patients seem to feel not ready 
for discharge. Van Galen et al27 showed that the patient reporting not 
feeling ready for discharge was strongly associated with predictability 
and preventability. Also, patients in our study who stated that their re-
admission was preventable were less satisfied about the information 
regarding medicines. Nowadays, patients are discharged as early as pos-
sible. As a consequence, it is a challenge to provide adequate patient ed-
ucation about their disease, medication purpose, medication changes, 
reason for changes and side-effects during short hospital stays. This 
TA B L E  3   Patients’ reported interventions for preventable medication-related readmissions (n = 21). Patients could mention more than 
one intervention
Question Yes, n (%)
All interventions 23
Hospital-based: 18 (78)
More diagnostics 6 (33)
Example patient's answer
‘I did not get enough medicines to get an adequate INR I asked to monitor my blood, however this was not done. I got discharged with an INR of 
1.2’.
Improving medication-related information 3 (17)
Example patient's answer
‘I was confused about my diuretics, one was started and one was stopped. I would get some diuretics upon discharge, however at discharge there 
was a lot of confusion and I did not get them. Not taking the diuretics could contribute to my rehospitalisation’
Longer hospital stay 3 (17)
Example caregiver's answer
‘My father was discharged too early. The neurologist could not find anything and he thought it was something with the heart. However, the cardi-
ologist refused to examine my father, so there was no follow-up. We thought something was wrong with the medication, but they did not listen 
to us. Now he is readmitted due to a way too low blood pressure’
Treating symptoms/complaints 3 (17)
Example patient's answer
‘The anti-inflammatory medicines should have been given longer, then the shortness of breath might not have come back’
Better aftercare 2 (11)
Example patient's answer
‘I read in the package leaflet that ciprofloxacin could cause pain in the Achilles tendon; I needed home care because I could not walk anymore 
because of the pain’
React faster 1 (6)
Example patient's answer:
‘I should have gotten a higher dose of dexamethasone earlier, then my readmission might have been prevented’
General practitioner–based: 2 (9)
React faster 2 (100)
Example patient's answer:  
‘My general practitioner should have arranged home care, because I needed help with daily self-care activities’
Patient based: 2 (9)
Therapy compliance 2 (100)
Example patient's answer:
‘I have mixed up Oxynorm® and Oxycontin®’
Other: 1 (4)
Unclassifiable due to lack of clear information 1 (100)
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suggests that more patient engagement is needed not only during hos-
pitalization, but also in the discharge process and the period after hos-
pitalization, especially for pharmaceutical care. This could be achieved 
by several methods, such as the use of lay language, asking patients 
what they want to know regarding their medicines, providing written 
information, repeating information or using the ‘teach-back’ method, 
which is a strategy in which patients are asked to restate information 
that has been presented to them.29 As previous studies have shown 
that patients’ needs can increase after discharge, also a follow-up phone 
call after discharge could be helpful to identify and to prevent medica-
tion-related problems.30-32 Further research should find out how these 
interventions could help to reduce medication-related readmissions.
The strength of this study is the description and comparison 
of the medication relatedness and potential preventability of re-
admissions according to perspectives of both patients and provid-
ers from several hospital departments. However, some limitations 
need to be discussed. This study is conducted in one hospital, 
which limits the generalizability. Another limitation is that patients 
were interviewed about the index admissions during readmission, 
which could lead to subjectivity and hindsight bias. However, in 
this way we could obtain information of the period after discharge 
of the index admission. Some patients could not be interviewed 
due to severe illness or unwillingness to participate. This could 
lead to selection bias as healthier or more satisfied patients were 
more often interviewed, which may have resulted in lower report-
ing of medication relatedness and preventability.
5  | CONCLUSION
Patients and providers differ substantially on their perspectives 
regarding medication relatedness and potential preventability of 
hospital readmissions. According to patients, medication-related 
readmissions occur more often and are more often potentially pre-
ventable compared with providers’ perspectives. Patients reported 
most often that actions on the hospital level were possible to poten-
tially prevent the readmission. Further studies need to explore the 
reasons for the gap between patients’ and providers’ perspectives.
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